Showing 2 posts of 2 posts found.
Leading UK oncologists have written an article in the May issue of The Lancet, strongly urging Britain to remain in …
Sarepta Therapeutics (NASDAQ: SPRT) is counting the cost as shares plunge following a negative review given by staff at the …
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
Highlighting the value of lab research for healthcare innovation
Capital Dynamics invests €14m in Italian community healthcare platform CareHub
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO